CorMedix (CRMD) EBT (2010 - 2026)
CorMedix (CRMD) posted EBT of $56.4 million for Q4 2025, up 7.36% sequentially from $52.6 million in Q3 2025, and up 319.23% YoY from $13.5 million in Q4 2024.
CorMedix (CRMD) EBT (2010 - 2026) Analysis & Trends
CorMedix has reported EBT for 16 years, with the latest figure at $56.4 million in Q4 2025.
- Quarterly EBT rose 319.23% year-over-year to $56.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $150.0 million (up 876.28% YoY) and the FY2025 annual result came in at $150.0 million, up 876.28% from the prior year.
- EBT advanced to $56.4 million in Q4 2025 per CRMD's latest filing, from $52.6 million in the prior quarter.
- Over five years, EBT peaked at $56.4 million in Q4 2025 and troughed at -$17.3 million in Q1 2021.
- A 5-year average of $671866.1 and a median of -$8.2 million in 2022 frame the typical range for EBT.
- The sharpest annual moves came in 2021 and 2025: EBT tumbled 199.88% in 2021, then surged 1993.4% in 2025.
- Over 5 years, EBT stood at -$7.8 million in 2021, then declined by 5.36% to -$8.2 million in 2022, then slumped by 79.73% to -$14.8 million in 2023, then surged by 191.26% to $13.5 million in 2024, then surged by 319.23% to $56.4 million in 2025.
- According to Business Quant data, EBT over the past three periods registered $56.4 million, $52.6 million, and $20.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 177.81 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -264.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -11.37 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | CorMedix | 645.20 Mn | 388.51 Mn | 77.13 Mn | 38.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.73 Mn |
| Dec 31, 2025 | 56.45 Mn |
| Sep 30, 2025 | 52.58 Mn |
| Jun 30, 2025 | 20.35 Mn |
| Mar 31, 2025 | 20.64 Mn |
| Dec 31, 2024 | 13.46 Mn |
| Sep 30, 2024 | -2.78 Mn |
| Jun 30, 2024 | -14.15 Mn |
| Mar 31, 2024 | -15.86 Mn |
| Dec 31, 2023 | -14.75 Mn |
| Sep 30, 2023 | -9.74 Mn |
| Jun 30, 2023 | -11.27 Mn |
| Mar 31, 2023 | -10.57 Mn |
| Dec 31, 2022 | -8.21 Mn |
| Sep 30, 2022 | -6.85 Mn |
| Jun 30, 2022 | -8.19 Mn |
| Mar 31, 2022 | -8.16 Mn |
| Dec 31, 2021 | -7.79 Mn |
| Sep 30, 2021 | -8.57 Mn |
| Jun 30, 2021 | -5.88 Mn |